Newronika

Private

MilanHealthcare & Life Scienceshttps://newronika.com/

Last Round

Series B

Feb 13, 2025

Total Funding Raised

$27.85M

Company Overview

Newronika is a medtech company that develops adaptive deep brain stimulation technology to treat neurological disorders such as Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

deep brain stimulationDBSadaptive deep brain stimulationaDBSclosed-loop stimulationimplantable medical deviceneuromodulationParkinson's disease treatmentmedical AIbrain biomarkerimplantable pulse generatorclinical data managementneurotechdigital healthhealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Newronika Comps

Public and private peers based on sector, stage, and business model.

Newronika comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Newronika Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Feb 13, 2025
VC Round	Jan 22, 2024
Grant	Mar 8, 2023
Series A	Sep 26, 2019
Seed	Jun 14, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Lorenzo Rossi

Chief Executive Officer

Executive Team

Newronika Investors

Notable investors and investment history

Newronika investors
Investor	Rounds
TNBT Capital	Series B
European Innovation Council Fund	Grant
Innogest Capital	Series A, Series B
Indaco Venture Partners SGR	Series A, Series B
F3F	Series A, Series B
Origine SGR	Series B, Seed
Wille Finance AG	Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 13, 2025
$14.1M round completed.

View all signals

Newronika Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Newronika Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Newronika's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilan

Employee Range25

Year Founded2016

Last FundingFeb 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.